Recent Advances and Hot Spots of Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Carcinoma

VernacularTitle:食管癌新辅助免疫治疗联合化疗的研究进展和热点问题
Author: Huilai LYU ¹ ; Chunyue GAI ¹ ; Mingbo WANG ¹ ; Zhenhua LI ¹ ; Jiachen LI ¹ ; Shi XU ¹ ; Weilu DING ¹ ; Yu LIU ¹ ; Ziqiang TIAN ¹
Author Information

1. Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Accurate Diagnosis and Comprehensive Treatment of Esophageal Cancer, Shijiazhuang 050011, China.
Publication Type:SPECIALFEATURE
Keywords: Esophageal cancer; Neoadjuvant treatment; Immunotherapy combined with chemotherapy
From: Cancer Research on Prevention and Treatment 2024;51(12):994-999
CountryChina
Language:Chinese
Abstract: Surgery-based multidisciplinary comprehensive treatment is the preferred treatment strategy for local advanced esophageal cancer. Neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy have been recommended by the Chinese Society of Clinical Oncology (CSCO) guideline. With the advent of immunotherapy, neoadjuvant immunotherapy combined with chemotherapy has received much attention, and the first phase Ⅲ study has also confirmed that neoadjuvant immunotherapy combined chemotherapy is a promising treatment option. This article will review the recent advances and hot spots of neoadjuvant immunotherapy combined with chemotherapy.